摘要
目的 探讨子宫内膜癌(endometrial cancer,EC)患者的住院费用情况.方法 选取福建省立医院 2016 年 1 月—2023年 12 月收治的 100 例EC患者进行回顾性分析,研究EC患者的基本情况与住院费用构成和变化趋势.结果 100 例EC患者各变量占比最高的分别为:年龄＞45～60 岁(51%)、住院天数＞10～20 d(69%)、医保支付(84%)、手术(79%)、一般病例类型(67%)、有合并症/并发症(63%).与 2016-2019 年的患者住院费用相比,2020-2023 年患者的抗菌药费(728.54±32.13)元、西药费(4 654.23±243.53)元更低,且患者的手术治疗费(7 178.24±359.46)元、非手术治疗项目费(555.28±13.64)元、护理费(1 226.37±33.61)元、麻醉费(1 921.35±185.42)元、诊断费(3 542.35±254.63)元、其他医疗费(4 857.42±166.28)元、总费用(32 147.59±1 324.28)元均更高,差异有统计学意义(P＜0.05).结论 EC患者的住院总费用存在上涨趋势,患者的经济负担较重.
Abstract
Objective To explore the hospitalization costs of patients with endometrial cancer(EC).Methods A retrospective analysis was conducted on 100 EC patients admitted to Fujian Provincial Hospital from January 2016 to December 2023 to study the basic situation,hospitalization cost composition,and changing trends of EC patients.Results The variables with the highest proportions among 100 EC patients were age>45-60 years(51%),length of hospital stay>10-20 d(69%),medical insurance payment(84%),surgical treatment(79%),general case type(67%),and comorbidities/complications(63%).Compared with the hospitalization costs of patients from 2016 to 2019,the antibacterial drug cost(728.54±32.13)yuan and western medicine cost(4 654.23±243.53)yuan for patients from 2020 to 2023 were lower,and the surgical treatment cost(7 178.24±359.46)yuan,non-surgical treatment project cost(555.28±13.64)yuan,nursing cost(1 226.37±33.61)yuan,anesthesia cost(1 921.35±185.42)yuan,diagnostic cost(3 542.35±254.63)yuan,other medical expenses(4 857.42±166.28)yuan,and total cost(32 147.59±1 324.28)yuan for patients were all higher,the differences were statistically significant(P<0.05).Conclusion The total hospitalization costs of EC patients is on the rise,and the economic burden on patients is relatively heavy.
万方数据